INVESTORS & MEDIA
News Release
Regeneron Announces Upcoming Investor Conference Presentations
- Goldman Sachs 41st Annual Global Healthcare Conference 2020 at
3:00 p.m. ET onTuesday, June 9, 2020
Credit Suisse Biotech Management & Board Call Series at8:00 a.m. ET onMonday, June 22, 2020
- BMO 2020 Prescriptions for
Success Healthcare Conference at10:00 a.m. ET onTuesday, June 23, 2020
The sessions may be accessed from the "Investors & Media" page of Regeneron's website at http://investor.regeneron.com/events-and-presentations. Replays of the webcasts will be archived on the Company's website for at least 30 days.
About Regeneron
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Contact Information:
Investor Relations
Justin Holko
914.847.7786
justin.holko@regeneron.com
View original content:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-investor-conference-presentations-301070837.html
SOURCE